Thorben Wilhelm Fründt

Thorben Wilhelm Fründt is a Physician Scientist affiliated with the University Medical Center Hamburg-Eppendorf and specifically works within the I. Medical Clinic and Polyclinic. His research focuses on hepatology, oncology, and immunotherapy, particularly in the context of hepatocellular carcinoma (HCC) and liver diseases.

• Key Research Themes: Liver cancer pathogenesis, immunotherapy safety, metabolomic biomarkers, and cross-talk between oral health and systemic diseases.
• Notable Work: Development of prognostic models for HCC patients, analysis of immune checkpoint inhibitors, and investigation of periodontal disease correlations in cirrhosis and NASH.

Publication Trends: Recent articles analyze metabolomic liquid biopsies for early HCC detection, PD-1/PD-L1 inhibitors in autoimmune liver disease, and circulating tumor cells as biomarkers. Collaborations span institutions across Europe, with a focus on real-world clinical data.

Advising & Collaborations: Co-author network includes experts in hepatology, oncology, and infectious diseases, indicating multidisciplinary teamwork in clinical trials and translational research.